Drugs / TER-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04753034 | Jan → May 2021 | atopic eczema | Teres Bio, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TER-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04753034 ↗ |
| Route | Topical | “TER-101 Topical Ointment” NCT04753034 ↗ |